Young RC - Search Results

1

ProMACE-MOPP combination chemotherapy for diffuse lymphomas.

Fisher RI, Young RC, Longo D, DeVita VT. Fisher RI, et al. Among authors: young rc. Semin Oncol. 1985 Mar;12(1 Suppl 2):29-32. Semin Oncol. 1985. PMID: 2579441

2

Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.

Fisher RI, Longo DL, DeVita VT Jr, Hubbard SM, Miller TP, Young RC. Fisher RI, et al. Among authors: young rc. Ann Oncol. 1991 Jan;2 Suppl 1:33-5. doi: 10.1093/annonc/2.suppl_1.33. Ann Oncol. 1991. PMID: 1710487 Free article. Review.

3

The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.

Young RC, Longo DL, Glatstein E, Ihde DC, Jaffe ES, DeVita VT Jr. Young RC, et al. Semin Hematol. 1988 Apr;25(2 Suppl 2):11-6. Semin Hematol. 1988. PMID: 2456618 Clinical Trial.

4

Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.

Longo DL, Glatstein E, Duffey PL, Ihde DC, Hubbard SM, Fisher RI, Jaffe ES, Gilliom M, Young RC, DeVita VT Jr. Longo DL, et al. Among authors: young rc. J Clin Oncol. 1989 Sep;7(9):1295-302. doi: 10.1200/JCO.1989.7.9.1295. J Clin Oncol. 1989. PMID: 2788716

5

The role of chemotherapy in diffuse aggressive lymphomas.

DeVita VT Jr, Hubbard SM, Young RC, Longo DL. DeVita VT Jr, et al. Among authors: young rc. Semin Hematol. 1988 Apr;25(2 Suppl 2):2-10. Semin Hematol. 1988. PMID: 3041598 Review.

6

Renal involvement in diffuse aggressive lymphomas: results of treatment with combination chemotherapy.

Geffen DB, Fisher RI, Longo DL, Young RC, DeVita VT Jr. Geffen DB, et al. Among authors: young rc. J Clin Oncol. 1985 May;3(5):646-53. doi: 10.1200/JCO.1985.3.5.646. J Clin Oncol. 1985. PMID: 3998781

7

Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.

Fisher RI, DeVita VT Jr, Hubbard SM, Longo DL, Wesley R, Chabner BA, Young RC. Fisher RI, et al. Among authors: young rc. Ann Intern Med. 1983 Mar;98(3):304-9. doi: 10.7326/0003-4819-98-3-304. Ann Intern Med. 1983. PMID: 6600902

8

Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.

Longo DL, Duffey PL, Jaffe ES, Raffeld M, Hubbard SM, Fisher RI, Wittes RE, DeVita VT Jr, Young RC. Longo DL, et al. Among authors: young rc. J Clin Oncol. 1994 Oct;12(10):2153-9. doi: 10.1200/JCO.1994.12.10.2153. J Clin Oncol. 1994. PMID: 7523607 Clinical Trial.

9

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.

Schein PS, DeVita VT Jr, Hubbard S, Chabner BA, Canellos GP, Berard C, Young RC. Schein PS, et al. Among authors: young rc. Ann Intern Med. 1976 Oct;85(4):417-22. doi: 10.7326/0003-4819-85-4-417. Ann Intern Med. 1976. PMID: 61732

10

Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.

Fisher RI, DeVita VT Jr, Johnson BL, Simon R, Young RC. Fisher RI, et al. Among authors: young rc. Am J Med. 1977 Aug;63(2):177-82. doi: 10.1016/0002-9343(77)90230-3. Am J Med. 1977. PMID: 70170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

708 results

Search Page

Filters